ALPMF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Astellas Pharma Inc

Watchlist Manager

Watchlist

Price: 17.5 USD 7.56% Market Closed

Market Cap: $31.4B

	Astellas Pharma Inc OTC:ALPMF	JP
	Angus Energy PLC F:A3R	UK
V	Vinci SA OTC:VCISF	FR
C	Copart Inc F:CO6	US
	Teradyne Inc NASDAQ:TER	US
	Advenica AB (publ) STO:ADVE	SE
	RFA Financial Inc TSX:RFA	CA
P	Poly Property Group Co Ltd OTC:PHKIF	HK
S	SBA Communications Corp F:4SB	US
E	Euro Manganese Inc OTC:EUMNF	CA
W	Woolworths Group Ltd OTC:WOLWF	AU

Profitability Summary

Astellas Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

81%

Strong 3Y Average Gross Margin

81%

Declining Gross Margin

82% > 81%

Healthy Operating Margin

21%

Sustainable 3Y Average Operating Margin

10%

Operating Margin is Increasing

10% > 21%

Healthy Net Margin

16%

Low 3Y Average Net Margin

Net Margin is Increasing

4% > 16%

Exceptional Free Cash Flow Margin

20%

Strong 3Y Average Free Cash Flow Margin

11%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.